Life sciences laboratory expansion for Cambridge

Glencar has been appointed by Chesterford Research Park, to build a new multi-occupancy, fully fitted laboratory and office building.

The 5,570m² three-storey building set within the Park’s 250-acre parkland environment is set to meet burgeoning demand within the Cambridge life sciences cluster.

The Sidney Sussex building will accommodate a mix of laboratory and office space in its multi-occupier design. Intended to meet both current and future needs, the facility will offer flexible suites ranging from 206m² to 781m².

Designed by architect BCRI, the building features open-plan office areas, lifts, storage rooms, and shower facilities, centred around a communal, light-filled atrium with a dedicated reception area.

Julian Cobourne, Head of Regional Investment Management at Aviva Investors, added: “We are pleased to continue progress in the creation of the Sidney Sussex Building, which will significantly enhance the breadth and depth of facilities at Chesterford Research Park. We believe this will reinforce the Park’s reputation as a location for some of the leading global names in life science.”

Chesterford Research Park, co-owned by Aviva Investors and Uttlesford District Council, is said to be a hub for innovation and is home to companies such as Arecor, AstraZeneca and Illumina.

Construction work for the project is due to complete by October 2025.